Role of DEPTOR in T Cell Activation and Alloimmunity
DEPTOR 在 T 细胞激活和同种免疫中的作用
基本信息
- 批准号:10062851
- 负责人:
- 金额:$ 70.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-12-08 至 2022-11-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAllograftingAntigensAreaBiologicalBiological Response Modifier TherapyBiologyCD4 Positive T LymphocytesCell CommunicationCell Differentiation processCell physiologyCellsCellular Metabolic ProcessChronicDevelopmentDiseaseEragrostisExcisionFOXP3 geneFRAP1 geneFundingGraft RejectionGraft SurvivalImmuneImmunobiologyIn VitroIndividualIntrinsic factorKnock-in MouseKnockout MiceLifeLinkLiteratureMetabolic PathwayMetabolismModelingNormal CellOrgan TransplantationOutcomePathologicPharmacologyPhenotypePhysiologicalPreventionProcessRegulationRegulatory T-LymphocyteResearchResearch ProposalsRoleSavingsSignal TransductionSirolimusT cell differentiationT-Cell ActivationT-Lymphocyte SubsetsTestingTherapeuticTransgenic MiceTransgenic OrganismsTransplantationUbiquitinationVascular Endothelial Cellallograft rejectioncancer cellcell typeclinically relevantcohesioneffector T cellend-stage organ failurefunctional outcomesgenetic regulatory proteinimmunoregulationin vivoin vivo Modelinhibitor/antagonistinnovationinsightisoimmunitymTOR Inhibitornoveloverexpressionpreventresponsesmall moleculetransplant model
项目摘要
Project Summary/Abstract
Allograft rejection is characterized by effector CD4+ T cell activation in response to donor antigen and an
intense cellular and humoral attack on the graft. However, multiple intracellular signals within CD4+ T cells
operate co-incidentally to enhance the expansion and function of CD4+Foxp3+ T regulatory cells that
collectively serve to control the alloimmune response. Furthermore, the potency of this process of
immunoregulation prevents and restrains alloimmune T effector cell activation and rejection. Importantly,
recent advances indicate that CD4+Foxp3+ T cell differentiation and function is negatively regulated by the
cell intrinsic activity of mTOR and specifically mTORC1. However, little is known about the regulation of
intracellular mTOR signaling within alloreactive CD4+ T cell effectors, or how its relative activity may be
modulated in Foxp3+ subsets, or whether it is possible to exploit modulatory signals to augment
physiological Treg activity in pathological states to prevent disease, including the development of chronic
allograft rejection. DEPTOR is a recently discovered cell intrinsic factor that modulates mTOR-induced
signaling responses in highly proliferative cancer cells, and it has more recently been observed to function
in normal cell types including vascular endothelial cells. In preliminary studies, we find that DEPTOR is
expressed at high levels in unactivated CD4+ T cells, and further, that its expression is reduced upon
cellular activation. In addition, we find that forced overexpression of DEPTOR modulates CD4+ T cell
activation responses in vitro, promotes immunoregulation and prolongs graft survival following fully MHC
mismatched transplantation in vivo. We suggest that these observations identify DEPTOR as a critical
upstream intracellular modulator of CD4+ T cell activation as well as the phenotypic and functional outcome
of the alloimmune response. Our objectives in this R01 are to further evaluate these observations using
novel transgenic mice, and 1), define the select function of DEPTOR in CD4+ T effector and regulatory
subsets in vivo, and 2), evaluate the consequences of CD4+ T cell DEPTOR expression in models of
transplant rejection. We will test the hypothesis that DEPTOR is a cell intrinsic molecule that modulates
CD4+ T effector cell activation and augments CD4+ T regulatory cell function to enhance immunoregulation
and promote long-term graft survival. We propose two specific aims in which we will: 1), determine the
consequences and mechanism of function of cell intrinsic DEPTOR in CD4+ T cell subsets, and 2),
determine the function of CD4+ T cell DEPTOR in long-term allograft survival. Collectively, these innovative
studies will have broad scientific and biological implications of great significance and relevance to
transplantation immunobiology.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David M. Briscoe其他文献
Risk factors for mortality in infants and young children on dialysis.
透析婴幼儿死亡的危险因素。
- DOI:
- 发表时间:
2001 - 期刊:
- 影响因子:13.2
- 作者:
Ellen G. Wood;Matthew Hand;David M. Briscoe;Lynn A. Donaldson;Verna Yiu;Frances L. Harley;B. Warady;Eileen N. Ellis - 通讯作者:
Eileen N. Ellis
A rendezvous before rejection: Where do T cells meet transplant antigens?
拒绝前的会合:T 细胞在何处与移植抗原相遇?
- DOI:
10.1038/nm0302-220 - 发表时间:
2002-03-01 - 期刊:
- 影响因子:50.000
- 作者:
David M. Briscoe;Mohamed H. Sayegh - 通讯作者:
Mohamed H. Sayegh
Inhibition of mevalonate metabolism by statins augments the immunoregulatory phenotype of vascular endothelial cells and inhibits the costimulation of CD4sup+/sup T cells
- DOI:
10.1111/ajt.16872 - 发表时间:
2022-03-01 - 期刊:
- 影响因子:8.200
- 作者:
Timna Agur;Johannes Wedel;Sayantan Bose;A.G. Pramoda Sahankumari;Daniel Goodman;Sek Won Kong;Chandra C. Ghosh;David M. Briscoe - 通讯作者:
David M. Briscoe
Outcome of renal transplantation in children less than two years of age
- DOI:
10.1038/ki.1992.331 - 发表时间:
1992-09-01 - 期刊:
- 影响因子:
- 作者:
David M. Briscoe;Melanie S. Kim;Craig Lillehei;Angelo J. Eraklis;Raphael H. Levey;William E. Harmon - 通讯作者:
William E. Harmon
David M. Briscoe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David M. Briscoe', 18)}}的其他基金
Role of DEPTOR in T Cell Activation and Alloimmunity
DEPTOR 在 T 细胞激活和同种免疫中的作用
- 批准号:
10302288 - 财政年份:2017
- 资助金额:
$ 70.8万 - 项目类别:
Function of DepTOR in T Cell Activation and Alloimmunity
DepTOR 在 T 细胞激活和同种免疫中的作用
- 批准号:
8785808 - 财政年份:2014
- 资助金额:
$ 70.8万 - 项目类别:
Vascular Endothelial Growth Factor Receptor Interactions and Allograft Rejection
血管内皮生长因子受体相互作用和同种异体移植排斥
- 批准号:
8239118 - 财政年份:2011
- 资助金额:
$ 70.8万 - 项目类别:
Role of T cell Specific Adaptor Protein in Alloimmunity
T 细胞特异性衔接蛋白在同种免疫中的作用
- 批准号:
8190975 - 财政年份:2011
- 资助金额:
$ 70.8万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 70.8万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 70.8万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 70.8万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 70.8万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 70.8万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 70.8万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 70.8万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 70.8万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 70.8万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 70.8万 - 项目类别:
Research Grant














{{item.name}}会员




